Dataset Information

ACBD6-related progressive neurodevelopmental disorder – chemical proteomics of YnMyr-labelled proteins in developing Danio rerio (zebrafish)

ABSTRACT: In triplicate for each condition, 12 WT and acbd6 F0 crispant Danio rerio (zebrafish) embryos were incubated with 20 μM YnMyr for 24 h, either between 48-72 hpf or 96-120 hpf. After labelling, zebrafish were washed twice with fresh egg water, deyolked, flash frozen in liquid nitrogen and stored at -80°C until further analysis.

INSTRUMENT(S): Orbitrap Eclipse

ORGANISM(S): Danio Rerio (zebrafish) (brachydanio Rerio)

TISSUE(S): Whole Body

SUBMITTER: Wouter Kallemeijn

LAB HEAD: Professor Edward W. Tate

PROVIDER: PXD043676 | Pride | 2024-06-16

REPOSITORIES: Pride

ACCESS DATA

Dataset's files

Source:

Items per page:

1 - 5 of 26

Publications

Bi-allelic ACBD6 variants lead to a neurodevelopmental syndrome with progressive and complex movement disorders.

Kaiyrzhanov Rauan R Rad Aboulfazl A Lin Sheng-Jia SJ Bertoli-Avella Aida A Kallemeijn Wouter W WW Godwin Annie A Zaki Maha S MS Huang Kevin K Lau Tracy T Petree Cassidy C Efthymiou Stephanie S Karimiani Ehsan Ghayoor EG Hempel Maja M Normand Elizabeth A EA Rudnik-Schöneborn Sabine S Schatz Ulrich A UA Baggelaar Marc P MP Ilyas Muhammad M Sultan Tipu T Alvi Javeria Raza JR Ganieva Manizha M Fowler Ben B Aanicai Ruxandra R Tayfun Gulsen Akay GA Al Saman Abdulaziz A Alswaid Abdulrahman A Amiri Nafise N Asilova Nilufar N Shotelersuk Vorasuk V Yeetong Patra P Azam Matloob M Babaei Meisam M Monajemi Gholamreza Bahrami GB Mohammadi Pouria P Samie Saeed S Banu Selina Husna SH Pinto Basto Jorge J Kortüm Fanny F Bauer Mislen M Bauer Peter P Beetz Christian C Garshasbi Masoud M Issa Awatif Hameed AH Eyaid Wafaa W Ahmed Hind H Hashemi Narges N Hassanpour Kazem K Herman Isabella I Ibrohimov Sherozjon S Abdul-Majeed Ban A BA Imdad Maria M Isrofilov Maksudjon M Kaiyal Qassem Q Khan Suliman S Kirmse Brian B Koster Janet J Lourenço Charles Marques CM Mitani Tadahiro T Moldovan Oana O Murphy David D Najafi Maryam M Pehlivan Davut D Rocha Maria Eugenia ME Salpietro Vincenzo V Schmidts Miriam M Shalata Adel A Mahroum Mohammad M Talbeya Jawabreh Kassem JK Taylor Robert W RW Vazquez Dayana D Vetro Annalisa A Waterham Hans R HR Zaman Mashaya M Schrader Tina A TA Chung Wendy K WK Guerrini Renzo R Lupski James R JR Gleeson Joseph J Suri Mohnish M Jamshidi Yalda Y Bhatia Kailash P KP Vona Barbara B Schrader Michael M Severino Mariasavina M Guille Matthew M Tate Edward W EW Varshney Gaurav K GK Houlden Henry H Maroofian Reza R

Brain : a journal of neurology 20240401 4

The acyl-CoA-binding domain-containing protein 6 (ACBD6) is ubiquitously expressed, plays a role in the acylation of lipids and proteins and regulates the N-myristoylation of proteins via N-myristoyltransferase enzymes (NMTs). However, its precise function in cells is still unclear, as is the consequence of ACBD6 defects on human pathophysiology. Using exome sequencing and extensive international data sharing efforts, we identified 45 affected individuals from 28 unrelated families (consanguinit ...[more]

PMID: 37951597

Similar Datasets

Project description:The acyl-CoA-binding domain-containing protein 6 (ACBD6) is ubiquitously expressed, plays a role in the acylation of lipids and proteins, and regulates the N-myristoylation of proteins via N-myristoyltransferase enzymes (NMTs). However, its precise function in cells is still unclear, as is the consequence of ACBD6 defects on human pathophysiology. Utilizing exome sequencing and extensive international data sharing efforts, we describe 43 affected individuals from 27 unrelated families with bi-allelic pathogenic, predominantly loss-of-function (18/20) variants in ACBD6. We generated zebrafish and Xenopus tropicalis acbd6 knockouts by CRISPR/Cas9 and characterized the role of ACBD6 on protein N-myristoylation with YnMyr chemical proteomics in the model organisms and human cells, with the latter also being subjected further to ACBD6 peroxisomal localization studies. The affected individuals (21 males and 22 females), with ages ranging from 1 to 50 years old, typically present with a complex and progressive disease involving moderate-to-severe global developmental delay/intellectual disability (100%) with significant expressive language impairment (97%), facial dysmorphism (94%), movement disorders (94%), and mild cerebellar ataxia (85%) associated with gait impairment (94%), limb spasticity/hypertonia (74%), oculomotor (68%) and behavioural abnormalities (63%), weight gain (59%), microcephaly (38%) and epilepsy (37%). The most conspicuous and common movement disorder was dystonia (90%), frequently leading to early-onset progressive postural deformities (93%), limb dystonia (40%), and cervical dystonia (25%). A jerky tremor in the upper limbs (61%), a mild head tremor (56%), parkinsonism/hypokinesia developing with advancing age (31%), and simple motor and vocal tics were among other frequent movement disorders. Midline brain malformations including corpus callosum abnormalities (66.6%), hypoplasia/agenesis of the anterior commissure (62.9%), short midbrain and small inferior cerebellar vermis (40.7% each), hypertrophy of the clava (18.5%) were common neuroimaging findings. Acbd6-deficient zebrafish and Xenopus models effectively recapitulated many clinical phenotypes reported in patients including movement disorders, progressive neuromotor impairment, seizures, microcephaly, craniofacial dysmorphism, and midbrain defects accompanied with developmental delay with increased mortality over time. Unlike ACBD5, ACBD6 did not show a peroxisomal localisation and ACBD6-deficiency was not associated with altered peroxisomal parameters in patient fibroblasts. Significant differences in YnMyr-labelling were observed for 68 co- and 18 post-translationally N-myristoylated proteins in patient-derived fibroblasts. N-Myristoylation was similarly affected in acbd6-deficient zebrafish and Xenopus models, including of FUS, MARCKS and CHCHD-related proteins implicated in neurological diseases. The present study provides evidence that bi-allelic pathogenic variants in ACBD6 lead to a distinct neurodevelopmental syndrome accompanied by complex and progressive cognitive and movement disorders.

			Action	DRS
	IA2736_kallemw_01.raw	Raw
	IA2736_kallemw_02.raw	Raw
	IA2736_kallemw_03.raw	Raw
	IA2736_kallemw_04.raw	Raw
	IA2736_kallemw_05.raw	Raw